Zhu Wei, Zhu Jianguo, Zhao Shengfa, Li Jieqing, Hou Dianjun, Zhang Yurong, Sun Hongliu
Institute of Radiation Medicine, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, China.
Juxian People's Hospital, Linyi, China.
Front Cell Neurosci. 2020 Oct 6;14:582872. doi: 10.3389/fncel.2020.582872. eCollection 2020.
Xenon has been shown to have neuroprotective effects and is clinically used as a favorable safe inhalation anesthetic. We previously confirmed the neuroprotective effects of xenon treatment in epileptic animals. However, the mechanism underlying these protective effects remains unclear. We aimed to assess the effects of xenon inhalation on autophagy in neuronal injury induced by acute generalized seizures. Kainic acid (KA) was injected into the lateral ventricle of male Sprague-Dawley rats to induce acute generalized seizures. Next, the rats were treated inhalation of a 70% xenon/21% oxygen/9% nitrogen mixture for 60 min immediately after KA administration. The control group was treated inhalation of a 79% nitrogen/21% oxygen mixture. Subsequently, two inhibitors (3-methyladenine or bafilomycin A) or an autophagy inducer (rapamycin) were administered, respectively, before KA and xenon administration to determine the role of autophagy in the protective effects of xenon. The levels of apoptosis, neuronal injury, and autophagy were determined in all the rats. Xenon inhalation significantly attenuated the severity of the seizure-induced neuronal injury. Increased autophagy accompanied this inhibitive effect. Autophagy inhibition eliminated these xenon neuroprotective effects. A simulation of autophagy using rapamycin recapitulated xenon's protective effects on KA-induced acute generalized seizures in the rats. These findings confirmed that xenon exerts strong neuroprotective effects in KA-induced acute generalized seizures. Further, they indicate that increased autophagy may underlie the protective effects of xenon. Therefore, xenon and autophagy inducers may be useful clinical options for their neuroprotective effects in epileptic seizures.
氙已被证明具有神经保护作用,临床上用作一种良好的安全吸入麻醉剂。我们之前证实了氙治疗对癫痫动物的神经保护作用。然而,这些保护作用的潜在机制仍不清楚。我们旨在评估吸入氙对急性全身性癫痫发作所致神经元损伤中自噬的影响。将 kainic 酸(KA)注入雄性 Sprague-Dawley 大鼠的侧脑室以诱导急性全身性癫痫发作。接下来,在给予 KA 后立即对大鼠进行 60 分钟的 70%氙/21%氧气/9%氮气混合物吸入治疗。对照组接受 79%氮气/21%氧气混合物吸入治疗。随后,在给予 KA 和氙之前分别给予两种抑制剂(3-甲基腺嘌呤或巴弗洛霉素 A)或自噬诱导剂(雷帕霉素),以确定自噬在氙保护作用中的作用。测定所有大鼠的凋亡水平、神经元损伤和自噬情况。吸入氙显著减轻了癫痫发作诱导的神经元损伤的严重程度。这种抑制作用伴随着自噬增加。抑制自噬消除了这些氙的神经保护作用。使用雷帕霉素模拟自噬重现了氙对大鼠 KA 诱导的急性全身性癫痫发作的保护作用。这些发现证实了氙在 KA 诱导的急性全身性癫痫发作中发挥强大的神经保护作用。此外,它们表明自噬增加可能是氙保护作用的基础。因此,氙和自噬诱导剂可能因其对癫痫发作的神经保护作用而成为有用的临床选择。